US 7378095
Methods of treating type I diabetes by blocking VEGF-mediated activity
granted A61KA61K38/179A61K38/28
Quick answer
US patent 7378095 (Methods of treating type I diabetes by blocking VEGF-mediated activity) held by REGENERON PHARMACEUTICALS, INC. expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K38/179, A61K38/28, A61K48/00, A61P